# Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion

> **NCT03405376** · PHASE4 · UNKNOWN · sponsor: **Yeungnam University College of Medicine** · enrollment: 49 (estimated)

## Conditions studied

- Branch Retinal Vein Occlusion With Macular Edema

## Interventions

- **DRUG:** Intravitreal aflibercept injection

## Key facts

- **NCT ID:** NCT03405376
- **Lead sponsor:** Yeungnam University College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-25
- **Primary completion:** 2019-03-31
- **Final completion:** 2020-09-30
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405376, "Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03405376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*